文献速递垂体与肾上腺疾病骨质疏松与钙磷/甲状旁腺

肢端肥大症中循环髓系钙化细胞持续减少:与骨-血管轴的相关性

Persistent Reduction of Circulating Myeloid Calcifying Cells in Acromegaly: Relevance to the Bone-Vascular Axis.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

本研究为横断面病例对照研究,比较44例肢端肥大症患者(25例活动期、19例非活动期)、44例匹配对照及8例治愈患者的循环髓系钙化细胞(MCC)。结果显示患者MCCs严重降低(0.17%±0.02% vs 1.00%±0.24%,P<0.001),非活动期及治愈后仍持续偏低,且MCCs与甲状旁腺激素直接相关。

要点

  • 肢端肥大症患者循环MCCs(OC+BAP+)较对照显著降低(0.17%±0.02% vs 1.00%±0.24%,P<0.001)。
  • 非活动期及治愈后患者MCCs水平仍持续降低。
  • 对照中糖尿病或心血管疾病者MCCs升高,但肢端肥大症患者无此变化。

核心结论

  • 肢端肥大症患者MCCs水平降低,且完全治愈多年后仍保持低水平,可能与低动脉粥样硬化钙化及病情缓解或治愈后骨病理持续存在有关。

研究设计与样本

  • 横断面病例对照研究,纳入44例肢端肥大症患者(25例活动期、19例非活动期)、44例按年龄、性别、危险因素及药物匹配的对照者和8例治愈的肢端肥大症患者。

主要发现

  • OC+BAP+ MCCs在肢端肥大症患者较对照严重降低(0.17%±0.02% vs 1.00%±0.24%,P<0.001),总OC+及BAP+单核细胞同样降低。
  • 非活动期肢端肥大症患者及治愈的肢端肥大症患者MCCs水平持续降低。
  • 对照中糖尿病或心血管疾病存在时MCCs升高,而肢端肥大症患者中无此变化。
  • MCCs与甲状旁腺激素呈直接相关(r=0.61;P<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Acromegaly is a systemic disease characterized by persistent bone pathology and excess cardiovascular mortality. Despite multiple concomitant risk factors, atherosclerosis does not seem to be accelerated in acromegaly. OBJECTIVE: To compare the levels of circulating myeloid calcifying cells (MCCs), which promote ectopic calcification and inhibit angiogenesis, in individuals with and without acromegaly. DESIGN: Cross-sectional case-control study. SETTING: Tertiary ambulatory referral endocrinology center. PATIENTS: 44 acromegalic patients (25 active; 19 inactive), 44 control subjects matched by age, sex, risk factors, and medications, and 8 patients cured of acromegaly. INTERVENTION: MCCs were measured using flow cytometry based on the expression of osteocalcin (OC) and bone alkaline phosphatase (BAP) on monocytes and circulating CD34+ stem cells. MAIN OUTCOME MEASURE: Differences in MCCs between patients and controls. RESULTS: OC+BAP+ MCCs were severely reduced in acromegalic compared with control patients (0.17% ± 0.02% vs 1.00% ± 0.24%; P < 0.001), as were the total OC+ and BAP+ monocytic cells. Patients with inactive acromegaly and those cured of acromegaly displayed persistently reduced levels of MCCs. In the controls, but not acromegalic patients, MCCs were increased in the presence of diabetes or cardiovascular disease. A direct correlation was noted between MCCs and parathyroid hormone (r = 0.61; P < 0.0001), supporting a link between bone biology and MCCs. CONCLUSIONS: In patients with acromegaly, the levels of MCCs are reduced and remain low, even years after a complete cure. This finding might be related to low atherosclerotic calcification and the persistence of bone pathology after acromegaly remission or cure.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Fadini GP, Dassie F, Cappellari R, et al. Persistent Reduction of Circulating Myeloid Calcifying Cells in Acromegaly: Relevance to the Bone-Vascular Axis. J Clin Endocrinol Metab. 2017. PMID: 28323966. doi:10.1210/jc.2017-00246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。